vs
Side-by-side financial comparison of Solventum (SOLV) and WEIBO Corp (WB). Click either name above to swap in a different company.
Solventum is the larger business by last-quarter revenue ($2.0B vs $1.3B, roughly 1.6× WEIBO Corp). WEIBO Corp runs the higher net margin — 35.7% vs 3.2%, a 32.5% gap on every dollar of revenue. Over the past eight quarters, WEIBO Corp's revenue compounded faster (22.6% CAGR vs -0.4%).
Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.
Weibo Corporation is a Chinese social network company known for the microblogging website Sina Weibo. It is based in Beijing, China.
SOLV vs WB — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.0B | $1.3B |
| Net Profit | $63.0M | $458.3M |
| Gross Margin | 51.4% | — |
| Operating Margin | 6.3% | 29.1% |
| Net Margin | 3.2% | 35.7% |
| Revenue YoY | -3.7% | — |
| Net Profit YoY | 103.2% | — |
| EPS (diluted) | $0.37 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.0B | — | ||
| Q3 25 | $2.1B | $1.3B | ||
| Q2 25 | $2.2B | $841.7M | ||
| Q1 25 | $2.1B | $396.9M | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.1B | $1.3B | ||
| Q2 24 | $2.1B | $833.4M | ||
| Q1 24 | $2.0B | $395.5M |
| Q4 25 | $63.0M | — | ||
| Q3 25 | $1.3B | $458.3M | ||
| Q2 25 | $90.0M | $234.8M | ||
| Q1 25 | $137.0M | $108.1M | ||
| Q4 24 | $31.0M | — | ||
| Q3 24 | $122.0M | $297.4M | ||
| Q2 24 | $89.0M | $164.6M | ||
| Q1 24 | $237.0M | $51.1M |
| Q4 25 | 51.4% | — | ||
| Q3 25 | 54.2% | — | ||
| Q2 25 | 54.4% | — | ||
| Q1 25 | 53.8% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 56.0% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 58.1% | — |
| Q4 25 | 6.3% | — | ||
| Q3 25 | 80.6% | 29.1% | ||
| Q2 25 | 9.9% | 30.4% | ||
| Q1 25 | 7.3% | 27.8% | ||
| Q4 24 | 6.6% | — | ||
| Q3 24 | 13.2% | 29.0% | ||
| Q2 24 | 11.7% | 28.2% | ||
| Q1 24 | 18.9% | 25.2% |
| Q4 25 | 3.2% | — | ||
| Q3 25 | 60.4% | 35.7% | ||
| Q2 25 | 4.2% | 27.9% | ||
| Q1 25 | 6.6% | 27.2% | ||
| Q4 24 | 1.5% | — | ||
| Q3 24 | 5.9% | 22.9% | ||
| Q2 24 | 4.3% | 19.8% | ||
| Q1 24 | 11.8% | 12.9% |
| Q4 25 | $0.37 | — | ||
| Q3 25 | $7.22 | — | ||
| Q2 25 | $0.51 | — | ||
| Q1 25 | $0.78 | — | ||
| Q4 24 | $0.18 | — | ||
| Q3 24 | $0.70 | — | ||
| Q2 24 | $0.51 | — | ||
| Q1 24 | $1.37 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $878.0M | $1.1B |
| Total DebtLower is stronger | $5.0B | — |
| Stockholders' EquityBook value | $5.0B | $3.9B |
| Total Assets | $14.3B | $6.9B |
| Debt / EquityLower = less leverage | 1.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $878.0M | — | ||
| Q3 25 | $1.6B | $1.1B | ||
| Q2 25 | $492.0M | $1.2B | ||
| Q1 25 | $534.0M | $1.2B | ||
| Q4 24 | $762.0M | — | ||
| Q3 24 | $772.0M | — | ||
| Q2 24 | $897.0M | $1.9B | ||
| Q1 24 | $996.0M | $2.1B |
| Q4 25 | $5.0B | — | ||
| Q3 25 | $5.1B | — | ||
| Q2 25 | $7.8B | — | ||
| Q1 25 | $7.9B | — | ||
| Q4 24 | $8.0B | — | ||
| Q3 24 | $8.1B | — | ||
| Q2 24 | $8.3B | — | ||
| Q1 24 | $8.3B | — |
| Q4 25 | $5.0B | — | ||
| Q3 25 | $5.0B | $3.9B | ||
| Q2 25 | $3.6B | $3.6B | ||
| Q1 25 | $3.3B | $3.5B | ||
| Q4 24 | $3.0B | — | ||
| Q3 24 | $3.2B | — | ||
| Q2 24 | $2.9B | $3.4B | ||
| Q1 24 | $3.9B | $3.3B |
| Q4 25 | $14.3B | — | ||
| Q3 25 | $14.0B | $6.9B | ||
| Q2 25 | $15.1B | $6.5B | ||
| Q1 25 | $14.5B | $6.7B | ||
| Q4 24 | $14.5B | — | ||
| Q3 24 | $14.7B | — | ||
| Q2 24 | $14.6B | $7.1B | ||
| Q1 24 | $14.7B | $7.3B |
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.14× | — | ||
| Q1 25 | 2.43× | — | ||
| Q4 24 | 2.71× | — | ||
| Q3 24 | 2.54× | — | ||
| Q2 24 | 2.90× | — | ||
| Q1 24 | 2.16× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $95.0M | — |
| Free Cash FlowOCF − Capex | $32.0M | — |
| FCF MarginFCF / Revenue | 1.6% | — |
| Capex IntensityCapex / Revenue | 3.2% | — |
| Cash ConversionOCF / Net Profit | 1.51× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-10.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $95.0M | — | ||
| Q3 25 | $76.0M | — | ||
| Q2 25 | $169.0M | — | ||
| Q1 25 | $29.0M | — | ||
| Q4 24 | $219.0M | — | ||
| Q3 24 | $169.0M | — | ||
| Q2 24 | $355.0M | — | ||
| Q1 24 | $442.0M | — |
| Q4 25 | $32.0M | — | ||
| Q3 25 | $-21.0M | — | ||
| Q2 25 | $59.0M | — | ||
| Q1 25 | $-80.0M | — | ||
| Q4 24 | $92.0M | — | ||
| Q3 24 | $76.0M | — | ||
| Q2 24 | $297.0M | — | ||
| Q1 24 | $340.0M | — |
| Q4 25 | 1.6% | — | ||
| Q3 25 | -1.0% | — | ||
| Q2 25 | 2.7% | — | ||
| Q1 25 | -3.9% | — | ||
| Q4 24 | 4.4% | — | ||
| Q3 24 | 3.7% | — | ||
| Q2 24 | 14.3% | — | ||
| Q1 24 | 16.9% | — |
| Q4 25 | 3.2% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 5.1% | — | ||
| Q1 25 | 5.3% | — | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 4.5% | — | ||
| Q2 24 | 2.8% | — | ||
| Q1 24 | 5.1% | — |
| Q4 25 | 1.51× | — | ||
| Q3 25 | 0.06× | — | ||
| Q2 25 | 1.88× | — | ||
| Q1 25 | 0.21× | — | ||
| Q4 24 | 7.06× | — | ||
| Q3 24 | 1.39× | — | ||
| Q2 24 | 3.99× | — | ||
| Q1 24 | 1.86× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SOLV
| Infection Prevention And Surgical Solutions | $752.0M | 38% |
| Cost Of Software And Rentals | $508.0M | 25% |
| Health Information Systems Segment | $347.0M | 17% |
| Dental Solutions Segment | $343.0M | 17% |
| Related Party | $14.0M | 1% |
WB
| Income from operations | $373.2M | 29% |
| Shares used in computing diluted net income per share attributable to Weibos shareholders | $268.1M | 21% |
| Shares used in computing basic net income per share attributable to Weibos shareholders | $238.6M | 19% |
| Value-added services | $186.1M | 14% |
| Less: Income tax expenses | $113.2M | 9% |
| Investment related income, net | $45.0M | 4% |
| Product development | $16.7M | 1% |
| General and administrative | $10.6M | 1% |
| Sales and marketing | $7.1M | 1% |
| Accretion to redeemable non-controlling interests | $3.0M | 0% |
